Citation Impact
Citing Papers
The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type
2012
Molecular Mechanisms of RET Receptor–Mediated Oncogenesis in Multiple Endocrine Neoplasia 2B
2006
Transient Ablation of Regulatory T cells Improves Antitumor Immunity in Colitis-Associated Colon Cancer
2014 StandoutNobel
Prognostic Significance of Somatic RET Oncogene Mutations in Sporadic Medullary Thyroid Cancer: A 10-Year Follow-Up Study
2007
The Increase in Thyroid Cancer Incidence During the Last Four Decades Is Accompanied by a High Frequency of BRAF Mutations and a Sharp Increase in RAS Mutations
2013
Recurrent BRAF mutations in Langerhans cell histiocytosis
2010 Standout
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
The role of m6A RNA methylation in human cancer
2019 Standout
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Mass spectrometry‐based metabolomics
2006 Standout
Decreased levels of serum glutathione peroxidase 3 are associated with papillary serous ovarian cancer and disease progression
2011
RNAscope
2011 Standout
The Cellular Basis of Tumor Progression
1997
Prognostic Factors in Well-Differentiated Follicular-Derived Carcinoma and Medullary Thyroid Carcinoma
2001
Thyroid cancer
2016 Standout
Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer
2001 Standout
Familial thyroid cancer: a review
2011
RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture
2006
Genetic profiling of intrahepatic cholangiocarcinoma
2012
Enhancing physical and social environments to reduce obesity among public housing residents: Rationale, trial design, and baseline data for the Healthy Families study
2014
Post-transcriptional gene regulation by mRNA modifications
2016 Standout
Curcumin induces G2/M arrest, apoptosis, NF-κB inhibition, and expression of differentiation genes in thyroid carcinoma cells
2017
Phaeochromocytoma
2005 Standout
Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma
2013
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
BRAF mutation in thyroid cancer
2005
Thyroid tumor marker genomics and proteomics: Diagnostic and clinical implications
2010
Detection of BRAF mutation in thyroid papillary carcinomas by mutant allele-specific PCR amplification (MASA)
2006
Long Noncoding RNAs in Cancer Pathways
2016 Standout
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
2013 Standout
Mechanisms of Disease: molecular genetics of childhood thyroid cancers
2007
Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings
2007
Central Role of RET in Thyroid Cancer
2013
Efficacy of imatinib mesylate in advanced medullary thyroid carcinoma
2007
Are we really at the dawn of understanding sporadic pediatric thyroid carcinoma?
2015
PTEN: One Gene, Many Syndromes
2003
Dynamic transcriptomic m6A decoration: writers, erasers, readers and functions in RNA metabolism
2018 Standout
A Founding Locus within the RET Proto-Oncogene May Account for a Large Proportion of Apparently Sporadic Hirschsprung Disease and a Subset of Cases of Sporadic Medullary Thyroid Carcinoma
2003
Somatic VHLgene alterations in MEN2-associated medullary thyroid carcinoma
2006
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
2005 Standout
Highly prevalent TERT promoter mutations in aggressive thyroid cancers
2013
Germline Homozygous Mutations at Codon 804 in theRETProtooncogene in Medullary Thyroid Carcinoma/Multiple Endocrine Neoplasia Type 2A Patients
2005
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
TheRETProto-Oncogene in Multiple Endocrine Neoplasia Type 2 and Hirschsprung's Disease
1996
Das medulläre Schilddrüsenkarzinom
2015
Distinct MultipleRET/PTC Gene Rearrangements in Multifocal Papillary Thyroid Neoplasia1
1998
Precursor lesions of endocrine system neoplasms
2013
Mutations of theRET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and Hirschsprung disease
1997
The essence of senescence: Figure 1.
2010 Standout
BRAFE600 in benign and malignant human tumours
2007
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Loss of Heterozygosity at theRETProtooncogene Locus in a Case of Multiple Endocrine Neoplasia Type 2A1
2001
Prognostic value of codon 918 (ATG?ACG)RET proto-oncogene mutations in sporadic medullary thyroid carcinoma
2001
m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer
2020 Standout
Defining the Role of mTOR in Cancer
2007 Standout
The functions and regulation of the PTEN tumour suppressor
2012 Standout
Printable organometallic perovskite enables large-area, low-dose X-ray imaging
2017 StandoutNature
Reading, writing and erasing mRNA methylation
2019 Standout
Multiple endocrine neoplasia type 2 andRET: from neoplasia to neurogenesis
2000
A census of human cancer genes
2004 Standout
Molecular genetics and diagnosis of thyroid cancer
2011
Cancer as an evolutionary and ecological process
2006 Standout
Radiation-induced thyroid cancer: What we have learned from Chernobyl
2006
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
2009 Standout
Intragenic Mutations in Thyroid Cancer
2008
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
2020 Standout
Association of legumain expression pattern with prostate cancer invasiveness and aggressiveness
2012
Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes
2004 StandoutNobel
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
2009 Standout
Low Prevalence of the Somatic M918T RET Mutation in Micro-Medullary Thyroid Cancer
2012
Lessons from Mouse Models of Thyroid Cancer
2009
A new mechanism of BRAF activation in human thyroid papillary carcinomas
2005
Childhood thyroid cancer in Belarus, Russia, and Ukraine after Chernobyl and at present
2007
MPLEx: a Robust and Universal Protocol for Single-Sample Integrative Proteomic, Metabolomic, and Lipidomic Analyses
2016
RET as a Diagnostic and Therapeutic Target in Sporadic and Hereditary Endocrine Tumors
2006
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013
2017 Standout
BRAF V600E and TERT Promoter Mutations Cooperatively Identify the Most Aggressive Papillary Thyroid Cancer With Highest Recurrence
2014
Familial Medullary Thyroid Carcinoma: Clinical Variability and Low Aggressiveness Associated withRETMutation at Codon 804
2002
Chemotherapy for advanced gastric cancer
2017 Standout
Pathogenesis, diagnosis and management of thyroid nodules in children
2006
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
The role of microRNA genes in papillary thyroid carcinoma
2005 Standout
End Points and Trial Design in Geriatric Oncology Research: A Joint European Organisation for Research and Treatment of Cancer–Alliance for Clinical Trials in Oncology–International Society of Geriatric Oncology Position Article
2013
Interventions for preventing obesity in children
2019 Standout
Blood CD33(+)HLA-DR(−) myeloid-derived suppressor cells are increased with age and a history of cancer
2013
Cancer treatment and survivorship statistics, 2016
2016 Standout
Proteome of Metastatic Canine Mammary Carcinomas: Similarities to and Differences from Human Breast Cancer
2010
Cancer treatment and survivorship statistics, 2019
2019 Standout
A systematic dissection of determinants and consequences of snoRNA-guided pseudouridylation of human mRNA
2022 StandoutNobel
Bioorthogonal Labeling of Human Prostate Cancer Tissue Slice Cultures for Glycoproteomics
2017 StandoutNobel
BRAF Mutation in Papillary Thyroid Cancer: Pathogenic Role, Molecular Bases, and Clinical Implications
2007
Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application
2018 Standout
Exposing the Thyroid to Radiation: A Review of Its Current Extent, Risks, and Implications
2010
Guidelines for the management of thyroid cancer
2014 Standout
RET Proto-Oncogene in the Development of Human Cancer
1999
The Treatment of Differentiated Thyroid Cancer in Children: Emphasis on Surgical Approach and Radioactive Iodine Therapy
2011
Dysregulation of the TSC-mTOR pathway in human disease
2004 Standout
Clinical Implications of Pre-Operative Rapid BRAF Analysis for Papillary Thyroid Cancer
2007
Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten
2004 StandoutNobel
Thyroid carcinoma
2003 Standout
Recent Advances in Genetics, Diagnosis, Localization, and Treatment of Pheochromocytoma
2001
Differentiated thyroid cancer in children and adults: same or distinct disease?
2007
Cancer treatment and survivorship statistics, 2014
2014 Standout
Works of Gerry Thomas being referenced
Human Thyroid Tumor Cell Lines Derived from Different Tumor Types Present a Common Dedifferentiated Phenotype
2007
Adjuvant chemotherapy in older women (ACTION) study – what did we learn from the pilot phase?
2011
Array comparative genomic hybridization identifies novel potential therapeutic targets in cholangiocarcinoma
2011
Profiling the Breast Cancer Proteome — The New Tool of the Future?
2006
Antimicrobials and in vitro systems: Antibiotics and antimycotics alter the proteome of MCF-7 cells in culture
2011
BRAFMutations Are Not a Major Event in Post-Chernobyl Childhood Thyroid Carcinomas
2004
Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas
2004
Genome-wide gene expression profiling suggests distinct radiation susceptibilities in sporadic and post-Chernobyl papillary thyroid cancers
2007
The Chernobyl Thyroid Cancer Experience: Pathology
2011
Simultaneously extracting DNA, RNA, and protein using kits: Is sample quantity or quality prejudiced?
2012
Heterogeneity in the Distribution ofRET/PTCRearrangements within Individual Post-Chernobyl Papillary Thyroid Carcinomas
2004
Resident Health Advocates in Public Housing Family Developments
2015
Novel candidate genes of thyroid tumourigenesis identified in Trk-T1 transgenic mice
2012
Mutation of theRETProto-Oncogene Is Correlated with RET Immunostaining in Subpopulations of Cells in Sporadic Medullary Thyroid Carcinoma1
1998
How Age Affects the Biology of Breast Cancer
2008
Frequency of BRAF T1796A mutation in papillary thyroid carcinoma relates to age of patient at diagnosis and not to radiation exposure
2005
A new route to thyrotoxicosis?
1995
Identification of Differentially Expressed Proteins in Triple-Negative Breast Carcinomas Using DIGE and Mass Spectrometry
2009
Heterogeneous mutation of the RET proto-oncogene in subpopulations of medullary thyroid carcinoma.
1996
TP53 codon 72 polymorphism in radiation-associated human papillary thyroid cancer
2006